adrenal medullary cells (7) and PC12 cells (8) . These results suggest that SERMs directly affect ion channels and subsequent cellular functions in a non-genomic manner.
Adrenal medullary cells are derived from the embryonic neural crest and share many physiological and pharmacological properties with postganglionic sympathetic neurons. Stimulation of AChRs in the cells increases the synthesis of catecholamines and causes the secretion of catecholamines into the systemic circulation (9, 10) . In bovine adrenal medullary cells, at least three distinct types of ionic channels are involved in catecholamine secretion (11) : nAChR-ion channels, voltagedependent Na + channels, and voltage-dependent Ca 2+ channels. In these cells, previous studies have shown that either carbachol (a synthetic derivative of ACh)-induced Na + influx via nAChR-ion channels or veratridineinduced Na + influx via voltage-dependent Na + channels increases Ca 2+ influx via voltage-dependent Ca 2+ channels, a prerequisite for the secretion (7, 11) and synthesis (10) of catecholamines. In contrast, high K + directly gates voltage-dependent Ca 2+ channels to increase Ca 2+ influx without increasing Na + influx (11) . Previously, we reported the occurrence and pharmacological characterization of estrogen receptors in the plasma membrane of bovine adrenal medulla (12) . Furthermore, phytoestrogens such as daidzein (13) and resveratrol (14) increased catecholamine synthesis through the plasma membrane estrogen receptors. In the present study, we examined the effects of two SERMs, raloxifene and tamoxifen, on [ 3 H]17b-estradiol (17b-E 2 ) binding to the membrane estrogen receptors, as well as catecholamine synthesis and secretion in cultured bovine adrenal medullary cells. We found that SERMs allosterically modulate [ 3 H]17b-E 2 binding to plasma membrane estrogen receptors and positively or negatively influence catecholamine synthesis and secretion in the cells.
Materials and Methods

Materials
Oxygenated Krebs-Ringer phosphate (KRP) buffer was used throughout. Its composition is as follows: 154 mM NaCl, 5.6 mM KCl, 1.1 mM MgSO 4 Ltd., Boston, MA, USA). Raloxifene and tamoxifen were dissolved in 100% dimethyl sulfoxide and then diluted in a reaction medium before use at a final concentration of dimethyl sulfoxide not exceeding 0.5% unless otherwise specified.
Isolation and primary culture of bovine adrenal medullary cells
Bovine adrenal medullary cells were isolated by collagenase digestion of adrenal medullary slices according to the previously reported method (15, 16 
C-catecholamine synthesis from [ C]tyrosine in the cells
After preincubation for 10 min, cells were incubated with 20 mM l-[U-
14 C]tyrosine (1 mCi) in KRP buffer in the presence or absence of various concentrations of raloxifene or tamoxifen and 300 mM ACh at 37°C for 20 min. After removing the incubation medium by aspiration, cells were harvested in 0.4 M perchloric acid and centrifuged at 1600 × g for 10 min.
14 C-Labelled catechol compounds were separated further by ion exchange chromatography on Duolite C-25 columns (H + -type, 0.4 × 7.0 cm) (10) and counted for the radioac-tivity by a Packard Tri-Carb 2900TR liquid scintillation counter.
14 C-Catecholamine synthesis was expressed as the sum of the 14 C-catecholamines (adrenaline, noradrenaline, and dopamine).
Catecholamine secretion from cultured bovine adrenal medullary cells
The secretion of catecholamines was measured as described previously (15) . After preincubation with or without raloxifene or tamoxifen at 37°C for 10 min, the cells (10 6 per well) were incubated with or without the SERMs in the presence or absence of various secretagogues at 37°C for another 10 min. After the reaction, the incubation medium was transferred immediately to a test tube containing perchloric acid (final concentration, 0.4 M). Catecholamines (noradrenaline and adrenaline) secreted into the medium were adsorbed onto aluminum hydroxide and estimated by the ethylendiamine condensation method using a fluorescence spectrophotometer (F-2500; Hitachi, Tokyo) with excitation and emission wavelengths of 420 and 540 nm, respectively. (11) . After preincubation with or without raloxifene or tamoxifen at 37°C for 10 min, the cells (4 × 10 6 per dish) were incubated with 1.5 mCi of 22 NaCl or 1.5 mCi of 45 CaCl 2 at 37°C for 5 min in the presence or absence of 300 mM ACh and various concentrations of the SERMs in KRP buffer. After incubation, the cells were washed 3 times with ice-cold KRP buffer, solubilized in 10% Triton X-100, and counted for radioactivity of 22 
Na
+ and 45 Ca 2+ by an Aloka ARC-2005 gamma counter and a Packard Tri-Carb 2900TR liquid scintillation counter, respectively.
Expression of nAChRs in Xenopus oocytes and electrophysiological recordings
Isolation and microinjection of Xenopus oocytes was performed as described previously (17, 18) . In brief, the cDNA encoding the a4 and b2 subunits of rat neuronal nAChR, subcloned into pcDNAI/Neo (Invitogen, Carlsbad, CA, USA) vector, was kindly provided from Dr. James W. Patrick (Division of Neuroscience, Baylor College of Medicine, Houston, TX, USA). Oocytes were injected with cDNAs (1.5 ng/30 nL) and electrophysiological recordings were performed 2 -3 days after injection. Each oocyte was perfused (2 mL/min) with Ba 2+ -Ringer's solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl 2 , and 10 mM HEPES, pH 7.4) containing 1 mM atropine sulfate, to minimize the effects of secondary activated Ca 2+ -dependant Cl − currents and then impaled with 2 glass electrodes (1 -5 MW) filled with 3 M KCl and clamped at −70 mV using the OC-725C Oocyte Clamp Amplifier (Harvard Apparatus, Inc., Holliston, MA, USA). ACh was applied for 30 s to obtain the maximum (peak) current used as a measure of drug response. We examined the effect of raloxifene (1 mM) on Na + current induced by ACh at a concentration that produced 50% of the maximal effect (EC 50 ) of ACh (1 mM).
Statistical analyses
All experiments were performed in duplicate or triplicate, and each experiment was repeated at least three times. All values are given as the mean ± S.E.M. The significance of differences between means was evaluated using one-way analysis of variance (ANOVA). When a significant F value was found by ANOVA, Dunnett's or Scheffe's test for multiple comparisons was used to identify differences among the groups. Values were considered statistically different when the P-value was less than 0.05. Statistical analyses were performed using PRISM for Windows version 5.0J software (Abacus Concept, Berkeley, CA, USA).
Results
Effects of raloxifene and tamoxifen on [ 3 H]17b-E 2 binding to plasma membranes
We first examined the effects of raloxifene and tamoxifen on the specific binding of [ 3 H]17b-E 2 to plasma membranes isolated from bovine adrenal medulla. When plasma membranes were incubated with these SERMs at various concentrations, the specific binding of [ 3 H]17b-E 2 was significantly increased by raloxifene and tamoxifen at 1.0 -10 nM (Fig. 1A ) and 1.0 nM -10 mM (except for 100 nM) (Fig. 1B) , respectively, but inhibited by raloxifene at 1.0 -10 mM (Fig. 1A) . These results suggest that the SERMs interact with plasma membrane estrogen receptors to positively or negatively modulate specific [ 3 H]17b-E 2 binding.
Effects of raloxifene and tamoxifen on basal and AChinduced 14 C-catecholamine synthesis from [ 14 C]tyrosine in the cells
Bovine adrenal medullary cells were incubated with 20 mM [ suggesting that the SERMs do not affect tyrosine uptake by the cells. ACh (300 mM) increased 14 C-catecholamine synthesis, which raloxifene and tamoxifen suppressed significantly (1.0 mM and 10 -100 mM, respectively) in a concentration-dependent manner (Fig. 2: C and D) .
Effects of pretreatment with raloxifene and tamoxifen on catecholamine secretion induced by ACh in the cells
Raloxifene (1 mM) and tamoxifen (10 mM) did not significantly affect basal secretion of catecholamines (control = 2.85% ± 0.17%, raloxifene = 3.21% ± 0.41%, tamoxifen = 3.47% ± 0.23% of the total catecholamines). Stimulation of nAChR-ion channels by ACh, a physiological secretagogue, caused catecholamine secretion corresponding to 16.79% ± 0.75% of the total catecholamines in the cells (Fig. 3A) . Pretreatment of cells with raloxifene (1 mM) (Fig. 3A) and tamoxifen (10 mM) (Fig. 3B) for 0, 5, 10, 20, and 30 min caused a timedependent decrease in catecholamine secretion induced by ACh for up to 30 min, with a continuously maximal reduced level occurring at 10 min. Therefore, the effect of SERMs on catecholamine secretion was evaluated using cells pretreated with SERMs for 10 min.
We examined the effects of raloxifene (1 mM) and tamoxifen (10 mM) on catecholamine secretion induced by other secretagogues. Veratridine (100 mM), an activator of voltage-dependent Na + channels, or 56 mM K + , an activator of voltage-dependent Ca 2+ channels, caused catecholamine secretion corresponding to 24.28% ± 1.58% and 19.47% ± 1.11% of the total catecholamines, respectively (Fig. 4A) . Raloxifene (1 mM) (Fig. 4A ) and tamoxifen (10 mM) (Fig. 4B) (10, 30 , and 100 mM) for 10 min reduced ACh-induced secretion of catecholamines to 81.0%, 65.0%, 35.1%, and 33.0% (Fig. 5A) or to 49.0%, 43.1%, and 25.4% (Fig. 6A) , respectively, of ACh alone in a concentration-dependent manner. Raloxifene suppressed ACh (300 mM)-induced 45 Ca 2+ influx at 1.0 -100 mM (Fig. 5B) and ACh (300 mM)-induced 22 Na + influx at 0.3 -100 mM (Fig. 5C ). Tamoxifen also inhibited ACh-induced 45 Ca 2+ influx (Fig. 6B ) and 22 Na + influx at 10 -100 mM (Fig. 6C) .
Inhibitory mode of raloxifene or tamoxifen on 22 Na
+ influx induced by ACh
We attempted to determine whether either SERM competes with ACh for binding sites on the nAChRs. When the concentration of ACh in the incubation medium increased, the inhibition of 22 
Na
+ influx induced by either SERM was not overcome by increasing concentrations (10 -300 mM) of ACh (Fig. 7: A and B) , indicating that neither SERM competes with ACh for the binding sites on nAChRs. 
Effects of raloxifene on ACh responses in Xenopus oocytes expressing nAChRs
The direct effect of raloxifene on ACh responses in Xenopus oocytes expressing rat a4b2 nAChRs was examined. As shown in Fig. 8 , raloxifene (1.0 mM) reversibly inhibited ACh-induced Na + currents.
Discussion
In the present study, we demonstrated the stimulatory or inhibitory effects of two SERMs, raloxifene and tamoxifen, on specific [ 3 H]17b-E 2 binding to plasma membrane estrogen receptors as well as catecholamine synthesis and secretion in bovine adrenal medullary cells.
Raloxifene and tamoxifen are allosteric modulators of plasma membrane estrogen receptors
SERMs are well-known to bind to estrogen-binding sites of classical nuclear ERs to initiate changes in formation on the ER, the dissociation of the ER from heat-shock proteins, and various gene transcriptions (2) . In the present study, raloxifene at 1.0 -10 nM and tamoxifen at 1.0 nM -10 mM except for 100 nM rather enhanced [ 3 H]17b-E 2 binding to plasma membrane estrogen receptors, whereas raloxifene at higher concentrations (1.0 -10 mM) inhibited it. This finding suggests that raloxifene and tamoxifen are an allosteric modulator of membrane estrogen receptors and that raloxifene at higher concentrations interferes with the specific binding of [ 3 H]17b-E 2 to membrane estrogen receptors. The former result is similar to that of our previous data produced by ICI182,780, a pure antagonist of nuclear ER, and p-nonylphenol or bisphenol A, environmental estrogenic pollutants, both of which allosterically enhanced specific [ 3 H]17b-E 2 binding to plasma membrane estrogen receptors (12) . 45 Ca 2+ influx and 22 Na + influx were measured, and expressed as nmol / 4 × 10 6 cells. Data are the mean ± S.E.M. of 4 separate experiments carried out in triplicate. *P < 0.05, **P < 0.01, and ***P < 0.001; compared to ACh alone. 
Modulatory effects of raloxifene and tamoxifen on 14 Ccatecholamine synthesis and catecholamine secretion
In bovine adrenal medullary cells, we previously reported that 17b-E 2 (12) , environmental estrogenic pollutants (19) , and phytoestrogens, such as daidzein (13) and resveratrol (14) , stimulate catecholamine synthesis through plasma membrane estrogen receptors. A previous study reported that activation of membrane estrogen receptors increases intracellular Ca 2+ concentrations and progesterone synthesis in rat hypothalamic astrocytes (20) . In the present study, however, the stimulatory effect of tamoxifen on 14 C-catecholamine synthesis may not be mediated through the plasma membrane estrogen receptors because it increased basal synthesis of 14 C-catecholamines only at 100 nM. Furthermore, at higher concentrations raloxifene (0.1 -1.0 mM) and tamoxifen (1.0 -10 mM) inhibited 14 Ccatecholamine synthesis. There was no relation between catecholamine synthesis and modulation of [ Both raloxifene (1.0 mM) and tamoxifen (10 -100 mM) suppressed ACh-induced 14 C-catecholamine synthesis in a concentration-dependent manner. We previously reported that ACh activates nAChR-ion channels, thereby inducing Na + influx and then Ca 2+ influx as well as catecholamine synthesis (10) and secretion (11) . In the present study, raloxifene and tamoxifen both preferentially inhibited catecholamine secretion mediated through nAChRs but neither did so through voltage-dependent Na + channels or voltage-dependent Ca 2+ channels. The present results were partially consistent with those of a previous report (7) that raloxifene at micromolar concentrations inhibited catecholamine output elicited by ACh or high potassium in perfused rat adrenal glands and cultured bovine adrenal medullary cells. In the present study, both SERMs suppressed ACh-induced 45 Ca influx and 22 
Na
+ influx in a concentration-dependent manner, similar to their suppression of catecholamine secretion and synthesis. It is likely that raloxifene and tamoxifen suppress ACh-induced catecholamine synthesis and secretion primarily by inhibiting Na + influx through nAChR-ion channels and subsequent Ca 2+ influx through voltage-dependent Ca 2+ channels. We further investigated the inhibitory mechanisms underlying the effects of raloxifene and tamoxifen on nAChR-ion channels. Increased concentrations of ACh did not overcome the inhibitory effects of the SERMs on ACh-induced 22 
+ influx, suggesting that the SERMs act on the sites differently than they act on ACh binding sites of nAChR-ion channels. We confirmed that raloxifene directly and reversibly suppressed AChinduced Na + current in Xenopus oocytes expressing rat a4b2 nAChR.
Pharmacological significance of the effects of the SERMs on catecholamine synthesis and secretion
The pharmacokinetic properties of raloxifene and tamoxifen in postmenopausal women and in women with breast cancer showed that the maximum plasma concentrations of raloxifene and tamoxifen were 2 -3 nM and 20 -330 nM, respectively, during clinical treatments (21, 22) . Tamoxifen, however, is reported to accumulate in tissues, resulting in 100-fold higher concentrations than in plasma after repeated administration of the drug during long-term treatment for breast cancer (23) . Therefore, the concentrations of raloxifene and tamoxifen used in the present study should be high, compared to those plasma therapeutic concentrations, but they might be clinically relevant in the tissues.
Several lines of evidence have shown that the SERMs have both potentially adverse (24) and beneficial effects on brain functions such as cognition (25, 26) and neuroprotection (27) . Indeed, raloxifene is reported to induce neurite outgrowth in estrogen receptor-positive PC12 cells (28) . In the present study, we demonstrated that low concentration of tamoxifen (100 nM) stimulates basal catecholamine synthesis, whereas at high concentrations, it inhibits basal and ACh-induced catecholamine synthesis and secretion. On the basis of the present results, it would be hypothesized that the SERMs negatively or positively modulate the functions of central noradrenergic or dopaminergic neurons, depending on their concentrations, by changing the synthesis and release of each neurotransmitter. To confirm this possibility, further in vivo studies are required in the near future.
In summary, we demonstrated that two SERMs, raloxifene and tamoxifen, allosterically interact with plasma membrane estrogen receptors, whereas at high concentrations each of them inhibits catecholamine synthesis and secretion induced by ACh in adrenal medullary cells and probably in peripheral and central sympathetic neurons.
